Literature DB >> 17960170

Genomic regions that influence plasma levels of inflammatory markers in hypertensive sibships.

K Ding1, D Feng, M de Andrade, T H Mosley, S T Turner, E Boerwinkle, I J Kullo.   

Abstract

We carried out univariate and bivariate linkage analyses to identify genomic regions that may influence plasma levels of C-reactive protein (CRP) and fibrinogen and exert pleiotropic effects on both traits. Subjects included African American (AA, n=1310, mean age 62.7+/-9.4 years) and non-Hispanic white (NHW, n=796, mean age 58.4+/-9.8 years) belonging to hypertensive sibships. Plasma CRP was measured by an immunoturbidimetric assay and fibrinogen by the Clauss method. Genotyping was performed at 366 microsatellite marker loci spaced approximately 10 cM apart across the 22 autosomes. Estimation of heritability and linkage analyses was carried out using a variance components approach. Significant heritability was noted for CRP (0.38 in AA and 0.37 in NHW subjects) and fibrinogen (0.44 in AA and 0.28 in NHW subjects). Significant genetic correlation between CRP and fibrinogen was present in both AA (0.39) and NHW (0.40) subjects. In univariate linkage analysis, the maximum logarithm of odds (LOD) score for CRP was on chromosome 10q22 in NHW (LOD=1.69, 106.75 cM, P=0.0026) and for fibrinogen on chromosome 2 in AA (LOD=2.14, 55.5 cM, P=0.0009) subjects. Bivariate linkage analysis demonstrated suggestive evidence of linkage (defined as LOD score >or= 2.87) for both traits on chromosome 12 (LOD=3.44, 152.16 cM, P=0.0003) in AA and on chromosome 21 (LOD=3.03, 13.05 cM, P=0.0008) in NHW subjects. Plasma CRP and fibrinogen levels are heritable and genetically correlated. Linkage analyses identified several chromosomal regions that may harbour genes influencing CRP and fibrinogen levels and exert pleiotropic effects on both traits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17960170      PMCID: PMC2842914          DOI: 10.1038/sj.jhh.1002297

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  59 in total

1.  Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli.

Authors:  M C Minnema; A C Chang; P M Jansen; Y T Lubbers; B M Pratt; B G Whittaker; F B Taylor; C E Hack; B Friedman
Journal:  Blood       Date:  2000-02-15       Impact factor: 22.113

2.  Microarray analysis of the in vivo effects of hypophysectomy and growth hormone treatment on gene expression in the rat.

Authors:  A Flores-Morales; N Ståhlberg; P Tollet-Egnell; J Lundeberg; R L Malek; J Quackenbush; N H Lee; G Norstedt
Journal:  Endocrinology       Date:  2001-07       Impact factor: 4.736

3.  C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.

Authors:  P M Ridker; C H Hennekens; J E Buring; N Rifai
Journal:  N Engl J Med       Date:  2000-03-23       Impact factor: 91.245

4.  The genetics of haemostasis: a twin study.

Authors:  M de Lange; H Snieder; R A Ariëns; T D Spector; P J Grant
Journal:  Lancet       Date:  2001-01-13       Impact factor: 79.321

5.  Familial and genetic determinants of systemic markers of inflammation: the NHLBI family heart study.

Authors:  J S Pankow; A R Folsom; M Cushman; I B Borecki; P N Hopkins; J H Eckfeldt; R P Tracy
Journal:  Atherosclerosis       Date:  2001-02-15       Impact factor: 5.162

6.  Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury.

Authors:  J I Leu; M A Crissey; J P Leu; G Ciliberto; R Taub
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

7.  Novel genomic loci influencing plasma homocysteine levels.

Authors:  Iftikhar J Kullo; Keyue Ding; Eric Boerwinkle; Stephen T Turner; Thomas H Mosley; Sharon L R Kardia; Mariza de Andrade
Journal:  Stroke       Date:  2006-06-01       Impact factor: 7.914

8.  Complete antithrombin deficiency in mice results in embryonic lethality.

Authors:  K Ishiguro; T Kojima; K Kadomatsu; Y Nakayama; A Takagi; M Suzuki; N Takeda; M Ito; K Yamamoto; T Matsushita; K Kusugami; T Muramatsu; H Saito
Journal:  J Clin Invest       Date:  2000-10       Impact factor: 14.808

9.  Abolition of anti-glomerular basement membrane antibody-mediated glomerulonephritis in FcRgamma-deficient mice.

Authors:  H Wakayama; Y Hasegawa; T Kawabe; T Hara; S Matsuo; M Mizuno; T Takai; H Kikutani; K Shimokata
Journal:  Eur J Immunol       Date:  2000-04       Impact factor: 5.532

10.  Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level.

Authors:  Sekar Kathiresan; Martin G Larson; Ramachandran S Vasan; Chao-Yu Guo; Philimon Gona; John F Keaney; Peter W F Wilson; Christopher Newton-Cheh; Stacy L Musone; Amy L Camargo; Jared A Drake; Daniel Levy; Christopher J O'Donnell; Joel N Hirschhorn; Emelia J Benjamin
Journal:  Circulation       Date:  2006-03-13       Impact factor: 29.690

View more
  8 in total

Review 1.  Between candidate genes and whole genomes: time for alternative approaches in blood pressure genetics.

Authors:  Jacob Basson; Jeannette Simino; D C Rao
Journal:  Curr Hypertens Rep       Date:  2012-02       Impact factor: 5.369

2.  Five blood pressure loci identified by an updated genome-wide linkage scan: meta-analysis of the Family Blood Pressure Program.

Authors:  Jeannette Simino; Gang Shi; Rezart Kume; Karen Schwander; Michael A Province; C Charles Gu; Sharon Kardia; Aravinda Chakravarti; Georg Ehret; Richard A Olshen; Stephen T Turner; Low-Tone Ho; Xiaofeng Zhu; Cashell Jaquish; Dina Paltoo; Richard S Cooper; Alan Weder; J David Curb; Eric Boerwinkle; Steven C Hunt; Dabeeru C Rao
Journal:  Am J Hypertens       Date:  2010-12-09       Impact factor: 2.689

3.  C-reactive Protein among Community-Dwelling Hypertensives on Single-agent Antihypertensive Treatment.

Authors:  Tibor Fulop; Andrew D Rule; Darren W Schmidt; Heather J Wiste; Kent R Bailey; Iftikhar J Kullo; Gary L Schwartz; Thomas H Mosley; Eric Boerwinkle; Stephen T Turner
Journal:  J Am Soc Hypertens       Date:  2009 Jul-Aug

4.  A QTL on 12q influencing an inflammation marker and obesity in white women: the NHLBI Family Heart Study.

Authors:  Jun Wu; James S Pankow; Russell P Tracy; Kari E North; Richard H Myers; Mary E Feitosa; Michael A Province; Ingrid B Borecki
Journal:  Obesity (Silver Spring)       Date:  2008-12-25       Impact factor: 5.002

5.  Implications of genetic polymorphisms in inflammation-induced atherosclerosis.

Authors:  Jayashree Shanker; Vijay V Kakkar
Journal:  Open Cardiovasc Med J       Date:  2010-02-23

6.  Linkage study of fibrinogen levels: the Strong Heart Family Study.

Authors:  Lyle G Best; Kari E North; Xia Li; Vittorio Palmieri; Jason G Umans; Jean MacCluer; Sandy Laston; Karin Haack; Harald Goring; Vincent P Diego; Laura Almasy; Elisa T Lee; Russell P Tracy; Shelley Cole
Journal:  BMC Med Genet       Date:  2008-08-12       Impact factor: 2.103

7.  Quantile-specific heritability of plasma fibrinogen concentrations.

Authors:  Paul T Williams
Journal:  PLoS One       Date:  2022-01-07       Impact factor: 3.240

8.  Genetic analysis of hsCRP in American Indians: The Strong Heart Family Study.

Authors:  Lyle G Best; Poojitha Balakrishnan; Shelley A Cole; Karin Haack; Jonathan M Kocarnik; Nathan Pankratz; Matthew Z Anderson; Nora Franceschini; Barbara V Howard; Elisa T Lee; Kari E North; Jason G Umans; Joseph M Yracheta; Ana Navas-Acien; V Saroja Voruganti
Journal:  PLoS One       Date:  2019-10-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.